[1]
|
何东东, 姚萍. 补充维生素D对炎症性肠病辅助治疗效果的研究进展[J]. 国际消化病杂志, 2021, 41(2): 80-83, 87.
|
[2]
|
王玉霞, 李君. 强化心理护理联合饮食干预对炎症性肠病患者免疫功能、心理状态及生活质量的影响[J]. 国际护理学杂志, 2021, 40(4): 627-630.
|
[3]
|
韦亚蓉, 陈婷婷, 杨武, 等. 炎症性肠病患者血清中AntiCABP水平检测的临床意义[J]. 中华炎性肠病杂志, 2021, 5(1): 55-61.
|
[4]
|
James, L.A., Gordon, W.M., DanieL, R.G., et al. (2021) SARS-CoV-2 Vaccination for Patients with Inflammatory Bowel Disease: A British Society of Gastroenterology Inflammatory Bowel Disease Section and IBD Clinical Research Group Position Statement. The Lancet Gastroenterology & Hepatology, 6, 218-224. https://doi.org/10.1016/S2468-1253(21)00184-9
|
[5]
|
郭新利, 李清文. 1例结肠克罗恩病误诊分析[J]. 局解手术学杂志, 2009, 18(2): 144-145.
|
[6]
|
Wilkinson, B., Trick, L., Knight, A., et al. (2019) Factors Associated with Depression in People with in Flammatory Bowel Disease: The Relationship between Active Disease and Biases in Neurocognitive Processing. Neurogastroenterology& Motility, 31, e13647. https://doi.org/10.1111/nmo.13647
|
[7]
|
Lisa, J.T.S., Aura, A.J., Lauranne, A., et al. (2019) Drug Survival and Immunogenicity after Switching from Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-Year Follow-Up of a Prospective Observational Cohort Study. Inflammatory Bowel Diseases, 25, 172-179. https://doi.org/10.1093/ibd/izy227
|
[8]
|
Chang, M.H., Chou, J.W., Chen, S.M., et al. (2014) Faecalcalprotectin as a Novel Biomarker for Differentiating between Inflammatory Bowel Disease and Irritable Bowel Syndrome. Molecular Medicine Reports, 10, 522-526. https://doi.org/10.3892/mmr.2014.2180
|
[9]
|
Liu, H., Hong, X.L., Sun, T.T., et al. (2020) Fusobacteriumnucleatum Exacerbates Colitis by Damaging Epithelial Barriers and Inducing Aberrant Inflammation. Journal of Digestive Diseases, 21, 385-398. https://doi.org/10.1111/1751-2980.12909
|
[10]
|
李灿, 李俊霞, 韩晓宁, 等. 北京市某三甲医院及社区全科医师炎症性肠病知晓情况和培训需求调查[J]. 中华全科医师杂志, 2021, 20(2): 194-198.
|
[11]
|
Argollo, M. and Danese, S. (2019) Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic. Current Pharmaceutical Design, 25, 5-6. https://doi.org/10.2174/138161282501190514105602
|
[12]
|
Frenkel, S., Bernstein, C.N., Sargent, M., et al. (2019) Genomewide Analysis Identifies Rare Copy Number Variations Associated with Inflammatory Bowel Disease. PLOS ONE, 14, e0217846. https://doi.org/10.1371/journal.pone.0217846
|
[13]
|
Tolstanova, G., Deng, X., Ahluwalia, A., et al. (2015) Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease. Digestive Diseases and Sciences, 60, 2963-2975. https://doi.org/10.1007/s10620-015-3698-5
|
[14]
|
蔡小莉, 赵豫鄂. 微视频形式的延续性护理教育对炎症性肠病患者生命质量、心理状态和满意度的影响[J]. 中国实用护理杂志, 2021, 37(10): 738-743.
|
[15]
|
Massart, A. and Hunt, D.P. (2020) Pulmonary Manifestations of Inflammatory Bowel Disease. The American Journal of Medicine, 133, 39-43. https://doi.org/10.1016/j.amjmed.2019.07.007
|
[16]
|
Sahoo, D.K., Heilmann, R., Paital, B., et al. (2023) Oxidative Stress, Hormones, and Effects of Natural Antioxidants on Intestinal Inflammation in Inflammatory Bowel Disease. Frontiers in Endocrinology, 14, Article 1217165. https://doi.org/10.3389/fendo.2023.1217165
|
[17]
|
Karthikeyan, A., Young, K.N., Moniruzzaman, M., et al. (2021) Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics, 13, Article 484. https://doi.org/10.3390/pharmaceutics13040484
|
[18]
|
Jellema, P., Van Tulder, M.W., Van Der Horst, H.E., et al. (2011) Inflammatory Bowel Disease: A Systematic Review on the Value of Diagnostic Testing in Primary Care. Colorectal Disease, 13, 239-254. https://doi.org/10.1111/j.1463-1318.2009.02131.x
|
[19]
|
Stewart, A., Sowden, D., Sloss, A. and Broom, J. (2019) Inflammatory Bowel Disease Masquerading as Traveller’s Diarrhoea. Internal Medicine Journal, 49, 789-791. https://doi.org/10.1111/imj.14311
|
[20]
|
宋振兴. 血常规检验对炎症性肠病的诊断效果分析[J]. 系统医学, 2022, 7(20): 83-86.
|
[21]
|
Allocca, M., Jovani, M. and Fiorino, G, (2013) Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target. Current Drug Targets, 14, 1508-1521. https://doi.org/10.2174/13894501113146660224
|
[22]
|
桂孟玹, 黄彬, 王瑞国, 等. 齐墩果酸通过调控IL-6/STAT3 信号通路影响结肠癌细胞的增殖和凋亡[J]. 中南药学, 2021, 19(3): 444-449.
|
[23]
|
王炼, 解巧丽, 王迅, 等. 脂肪因子Chemerin拮抗剂对白介素-10基因敲除小鼠结肠炎和肠系膜病变的影响及其可能机制[J]. 中华炎性肠病杂志, 2020, 4(1): 40-46.
|
[24]
|
Stout, M.B., Justice, J.N., Nicklas, B.J. and Kirkland, J.L. (2017) Physiological Aging: Links among Adipose Tissue Dysfunction, Diabetes, and Frailty. Physiology, 32, 9-19. https://doi.org/10.1152/physiol.00012.2016
|
[25]
|
刘春辉, 刘兆润, 董丽, 等. 炎症性肠病患者的血清IL-6、SICAM-1、Chemerin的水平变化与意义[J]. 中国医学创新, 2022, 19(5): 119-123.
|
[26]
|
Preiß, J.C., Schneidereit, O., Siegmund, B. and Hoffmann, J.C. (2019) Improving Treatment of Patients with Inflammatory Bowel Diseases: A Controlled Trial of a Multifaceted Intervention in Two German Cities. International Journal of Colorectal Disease, 34, 1233-1240. https://doi.org/10.1007/s00384-019-03317-y
|
[27]
|
周露, 高一雯, 路国涛, 等. 脂肪因子Chemerin与代谢综合征研究进展[J]. 医学综述, 2021, 27(3): 417-421, 427.
|
[28]
|
Lei, W. and Duan, Z. (1964) Advances in the Treatment of Cholinergic Anti-Inflammatory Pathways in Gastrointestinal Diseases by Electrical Stimulation of Vagusnerve. Digestion, 102, 128-138. https://doi.org/10.1159/000504474
|
[29]
|
Lucy, S. and Haleh, V. (2018) Hepatotoxicity of Inflammatory Bowel Disease Medications. Journal of Clinical Gastroenterology, 52, 674-684. https://doi.org/10.1097/MCG.0000000000001084
|
[30]
|
王松, 陈霞. 免疫检查点抑制剂相关神经系统不良事件: 从机制到治疗[J]. 中国神经免疫学和神经病学杂志, 2021, 28(1): 61-66.
|
[31]
|
Pedersen, J.E., Ängquist, L.H., Jensen, C.B., et al. (2020) Risk of Pancreatitis in Patients with Inflammatory Bowel Disease—A Meta-Analysis. Danish Medical Journal, 67, A08190427.
|
[32]
|
Rawish, E., Sauter, M., Sauter, R., Nording, H. and Langer, H.F. (2021) Complement, Inflammation and Thrombosis. British Journal of Pharmacology, 178, 2892-2904. https://doi.org/10.1111/bph.15476
|
[33]
|
Holtman, G.A., Lisman-Van Leeuwen, Y., Reitsma, J.B., et al. (2016) Noninvasive Tests for Inflammatory Bowel Disease: A Meta-Analysis. Pediatrics, 137, e20152126. https://doi.org/10.1542/peds.2015-2126
|
[34]
|
Ju, J.B., Zhang, P.X. and Jiang, B.G. (2019) Hip Replacement as Alternative to Intramedullary Nail in Elderly Patients with Unstable Intertrochanteric Fracture: A Systematic Review and Meta Analysis. Orthopaedic Surgery, 11, 745-754. https://doi.org/10.1111/os.12532
|
[35]
|
Van Rheenen, P.F., Van De Vijver, E. and Fidler, V. (2010) Faecalcalprotectin for Screening of Patients with Suspected Inflammatory Bowel Disease: Diagnostic Meta-Analysis. BMJ, 341, c3369. https://doi.org/10.1136/bmj.c3369
|
[36]
|
Freeman, K., Willis, B.H., Fraser, H., et al. (2019) Faecalcalprotectin to Detect Inflammatory Bowel Disease: A Systematic Review and Exploratory Meta-Analysis of Test Accuracy. BMJ Open, 9, e027428. https://doi.org/10.1136/bmjopen-2018-027428
|
[37]
|
姜焕鲁. 血常规检验诊断炎症性肠病临床探讨[J]. 心理月刊, 2019, 14(3): 134.
|
[38]
|
徐君霞. 血常规检验在炎症性肠病诊断中的价值[J]. 中国肛肠病杂志, 2019, 39(1): 31-33.
|
[39]
|
何青. 血常规检验诊断炎症性肠病的应用[J]. 医学美学美容, 2021, 30(3): 172.
|
[40]
|
关喜华. 炎症性肠病的血常规特点及其意义[J]. 中国当代医药, 2020, 27(5): 177-180.
|
[41]
|
王康. 血常规检验诊断炎症性肠病的效果分析[J]. 系统医学, 2022, 7(17): 69-72.
|
[42]
|
Van Der Meijden, P.E.J. and Heemskerk, J.W.M. (2019) Platelet Biology and Functions: New Concepts and Clinical Perspectives. Nature Reviews Cardiology, 16, 166-179. https://doi.org/10.1038/s41569-018-0110-0
|
[43]
|
梅敏慧. 炎症性肠病患者血小板和凝血功能分析[D]: [硕士学位论文]. 武汉: 华中科技大学, 2019.
|
[44]
|
黄乐曦, 赵海滨, 刘果. 宋乃光教授运用伏邪理论调治难治性炎症性肠病经验[J]. 环球中医药, 2021, 14(10): 1812-1814.
|
[45]
|
沈洪, 邢敬, 朱磊, 等. 炎症性肠病中西医结合治疗策略的探索与实践[J]. 北京中医药, 2020, 39(3): 191-195. https://doi.org/10.16025/j.1674-1307.2020.03.001
|
[46]
|
纪茜茜, 侯晓菲, 仲颖, 等. 基于数据挖掘针灸治疗炎症性肠病的主穴运用规律分析[J]. 山西中医药大学学报, 2020, 21(3): 161-165. https://doi.org/10.19763/j.cnki.2096-7403.2020.03.02
|
[47]
|
苏晓兰, 国嵩, 张涛, 等. 炎症性肠病诊治现状及中医药治疗特色与优势[J]. 北京中医药, 2020, 39(3): 211-215. https://doi.org/10.16025/j.1674-1307.2020.03.005
|
[48]
|
周先炎. 中医“和法”在消化系统常见病治疗中的应用价值分析[J]. 河南医学研究, 2015, 24(11): 141-142.
|